How many insider trades does FilingIQ track for RAPT?

FilingIQ tracks 404 Form 4 insider transactions for RAPT (RAPT Therapeutics, Inc.), covering filings from Nov 4, 2019 onwards. 76 of those were filed in the last 90 days.

Are RAPT insiders net buyers or net sellers?

Across the full Form 4 history for RAPT, 76 transactions (19%) were open-market purchases and 144 (36%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does RAPT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is RAPT in?

RAPT Therapeutics, Inc. (RAPT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.67B.

RAPT insider trading

Healthcare

RAPT Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

404

Last 90 days

Buys / sells

19% / 36%

Market cap

$1.67B

About RAPT Therapeutics, Inc.

RAPT Therapeutics, Inc. operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. The company's lead inflammation drug candidate is zelnecirnon (RPT193), a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Its lead oncology drug candidate is tivumecirnon (FLX475), an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California. RAPT Therapeutics, Inc. is a subsidiary of Bristol-Myers Squibb Company.

Company website: www.rapt.com

RAPT insider activity at a glance

FilingIQ has scored 404 insider transactions for RAPT since Nov 4, 2019. The most recent filing in our index is dated Mar 3, 2026.

Across the full history, 76 open-market purchases and 144 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on RAPT insider trades is 52.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live RAPT trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for RAPT?: FilingIQ tracks 404 Form 4 insider transactions for RAPT (RAPT Therapeutics, Inc.), covering filings from Nov 4, 2019 onwards. 76 of those were filed in the last 90 days.
Are RAPT insiders net buyers or net sellers?: Across the full Form 4 history for RAPT, 76 transactions (19%) were open-market purchases and 144 (36%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does RAPT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is RAPT in?: RAPT Therapeutics, Inc. (RAPT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.67B.

Methodology & sources

Every RAPT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.